While targeted therapies offer higher progression-free survival rates, and are less invasive than standard treatment (such as chemotherapy and radiation), they can also be relatively pricey. Fortunately, our cancer research and patient advocacy experts are able to get the costs of these advanced treatments covered for our clients, much of the time.
Targeted therapies are the newest medical advancement in cancer treatment. It’s quite common for CTOAM to recommend targeted treatments that are already being used in hospitals for one particular form of cancer, but not your unique form of cancer. This is because the most recent research has not yet made its way down to the front lines. Even if all the scientific evidence and clinical trials demonstrate that the drug would be beneficial for you, it might not yet be FDA approved for your particular form of cancer.
So what does this mean for cancer patients who need targeted treatments that aren’t readily available to them?
Keep in mind that there’s a huge amount of research already done on these drugs, and an expert like CTOAM’s Alex Rolland knows exactly which drugs will benefit your unique form of cancer. Whenever CTOAM recommends a drug that must be accessed through compassionate care, it is because all of our research shows that the benefits far outweigh any potential risks.
CTOAM has also built trusted relationships with pharmaceutical companies over the many years we’ve been offering precision oncology services. These connections allow for even greater success, by providing you access to the most advanced cancer drugs through compassionate care, at no cost to you.
Register for a Precision Second Opinion, to discover how you can access the most advanced tests and treatments that medical science has to offer.
CTOAM: Everything you need.
Get the latest advancements in cancer care delivered straight to your inbox each month!